Integrated Research (ASX: IRI) is an Australian-listed company in the Technology sector with a market capitalisation of $50.6M and the 1010th-largest security on the ASX by market capitalisation. The IRI share price is $0.28, up 0.00% today and down 30.86% over the past 12 months. Shares have traded between $0.27 and $0.51 over the past 52 weeks. IRI pays a trailing dividend yield of 5.65%. In its most recent reported period (ending 31 Dec 2025), Integrated Research reported revenue of $28.3M and a net loss of $1.5M.
About Integrated Research Limited
Integrated Research Limited (IRI.AX), an Australian company founded in North Sydney in 1988, specializes in developing, deploying, and selling computer software for managing critical IT systems. Their solutions address business-critical computing, unified communication, and payment networks. The company's flagship product, Prognosis, is a comprehensive software suite engineered to provide management and technical teams with detailed operational insight into platforms such as HP NonStop, distributed system servers, unified communications environments, payment infrastructures, and core business applications. Beyond software, they also deliver testing, maintenance, and professional services, including a Software-as-a-Service (SaaS) option. Integrated Research operates globally, reaching clients in approximately 60 countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, complemented by a broad international channel-driven distribution network. Their diverse customer base includes financial institutions like stock exchanges, banks, and credit card companies, alongside telecommunications carriers, service providers, and manufacturers.
